• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Designed a new model to predict the life expectancy of a severe neurodegenerative disease

Bioengineer by Bioengineer
July 15, 2020
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Bellvitge Biomedical Research Institute (IDIBELL)

Creutzfeldt-Jakob disease (CJD) is a serious minority neurodegenerative disease, with an annual rate of 1.5 cases per million inhabitants, which represents approximately 11 cases each year in Catalonia. CJD is a very rapid and fatal disease, in fact, the mean life expectancy is six months after diagnosis. The characteristic symptoms are dementia and the rapid and progressive loss of motor and mental abilities. A team from the Bellvitge Biomedical Research Institute (IDIBELL) and CIBERNED, together with two German research groups from the University of Göttingen and the University of Münster (WWU), have just designed a very user-friendly model that will allow determining the life expectancy of CJD patients at the diagnosis moment.

The model, presented in an article in the Alzheimer’s and Dementia journal, has been created based on four basic parameters that all doctors have at the time of CJD diagnosis: age, sex, variant of the prion protein gene (PRNP) and the concentration of the tau protein in the cerebrospinal fluid. In CJD patients, the PRNP gene is frequently sequenced to determine if the origin of the disease is genetic or sporadic, so it is easy to know which of the three possible variants of this gene is present. On the other hand, the concentration of tau in the cerebrospinal fluid is an indicator of neuronal damage, frequently measured in the diagnosis of neurodegenerative diseases.

The team, in which Dr. Franc Llorens, principal investigator of the IDIBELL Neuropathology group and CIBERNED has participated, has designed six tables that combine the four basic parameters and allows the extrapolation of patients’ life expectancy. “This is the first model for the prognosis of patients with CJD,” says Dr. Llorens, and adds, “it is a user-friendly tool that does not require prior knowledge of statistics, epidemiology or the disease itself.” The researchers are satisfied with the forecast accuracy of this new model, they consider it “a good starting point to optimizing with new factors that may be interesting in the future,” says Dr. Nicole Rübsamen of the University of Münster.

Why knowing life expectancy is so important?

For family conciliation, knowing the life expectancy of a patient helps the family and the patient himself to prepare for the final moment, also allows palliative care and therapeutic support to be adapted, and thus improve the quality of life. But also, knowing this information is useful for the efficacy studies of new treatments for the disease. If we do not know what the initial life expectancy was, we cannot determine if a specific treatment has brought him a benefit, and therefore, the lengthening of life expectancy.

In neurodegenerative diseases, especially those with rapid progression, one of the best ways to know if a treatment works is to determine if it lengthens life expectancy. This can only be determined if we can predict the initial life expectancy, before treatment, and compare it with that obtained after treatment. These are much more reliable and objective data than neuropsychological analyzes, where there are always subjective components, and in many cases, they cannot be performed in these patients.

The largest cohort in the world

This study shows results from the world’s largest cohort of CJD patients, over 1,200 cases. This is a rare disease, with a very low prevalence, that is why it took to the National Reference Center in Germany 25 years, from 1993 to 2017, to gather enough data to do a study.

###

Media Contact
Carla Serra-Peinado
[email protected]

Original Source

https://idibell.cat/en/2020/07/designed-a-new-and-user-friendly-model-to-predict-the-life-expectancy-of-a-severe-neurodegenerative-disease/

Related Journal Article

http://dx.doi.org/10.1002/alz.12133

Tags: Medicine/Healthneurobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

SH3BP5: A Key to DLBCL Immunotherapy Progress

September 25, 2025

Isothermal Solidification Powers High-Entropy Alloy Synthesis

September 25, 2025

Empowering Indigenous Youth: Hope in Diabetes Prevention

September 25, 2025

New Insights into LUAD: Immunogenic Cell Death and Environment

September 25, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    71 shares
    Share 28 Tweet 18
  • Physicists Develop Visible Time Crystal for the First Time

    71 shares
    Share 28 Tweet 18
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    51 shares
    Share 20 Tweet 13
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    50 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

SH3BP5: A Key to DLBCL Immunotherapy Progress

Ribonucleotides in Mitochondria Trigger Inflammation

Quasi-1D Modeling Boosts GAA MOSFET Simulations

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.